Form 4 Tracker
Adaptive Biotechnologies Corp
ADPT

71 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 16, 2026Jul 20 11:19 PMSusan BobulskyChief Commercial Officer, MRD
Sale
5,000$23.00$115.0K401,288(D)

View →

Jul 15, 2026Jul 17 11:23 PMFrancis LOChief People Officer
Sale
105,762$22.59$2.4M230,713(D)

View →

Jul 16, 2026Jul 16 8:34 PMSUSAN BOBULSKY
Proposed Sale
5,000$22.90$114.5K—

View →

Jul 2, 2026Jul 7 10:52 PMHarlan S RobinsChief Scientific Officer
Sale
386,240$22.01$8.5M1,019,658(D)

View →

Jul 2, 2026Jul 6 11:19 PMFrancis LOChief People Officer
Sale
44,838$22.59$1.0M230,713(D)

View →

Jul 1, 2026Jul 6 11:19 PMFrancis LOChief People Officer
Sale
51,004$22.45$1.1M237,688(D)

View →

Jul 1, 2026Jul 6 11:15 PMSusan BobulskyChief Commercial Officer, MRD
Sale
487$22.00$10.7K406,288(D)

View →

Jul 2, 2026Jul 2 9:43 PMHarlan Robins
Proposed Sale
386,240$21.19$8.2M—

View →

Jul 1, 2026Jul 1 8:35 PMFRANCIS LO
Proposed Sale
199,260$21.45$4.3M—

View →

Jul 1, 2026Jul 1 8:16 PMSUSAN BOBULSKY
Proposed Sale
487$21.45$10.4K—

View →

Jun 29, 2026Jun 30 11:25 PMSharon BenzenoChief Commercial Ofc Imm Med
Sale
154,768$21.14$3.3M221,278(D)

View →

Jun 26, 2026Jun 30 11:25 PMSharon BenzenoChief Commercial Ofc Imm Med
Sale
11,034$21.00$231.7K272,751(D)

View →

Jun 25, 2026Jun 29 11:52 PMSusan BobulskyChief Commercial Officer, MRD
Sale
5,000$20.50$102.5K406,775(D)

View →

Jun 25, 2026Jun 29 11:49 PMMichelle Renee GriffinDirector
Sale
52,084$20.18$1.1M15,625(D)

View →

Jun 29, 2026Jun 29 8:48 PMSHARON BENZENO
Proposed Sale
152,931$20.96$3.2M—

View →

Jun 26, 2026Jun 26 8:42 PMSHARON BENZENO
Proposed Sale
12,871$20.25$260.6K—

View →

Jun 25, 2026Jun 25 8:26 PMSUSAN BOBULSKY
Proposed Sale
5,000$19.34$96.7K—

View →

Jun 25, 2026Jun 25 8:26 PMMICHELLE GRIFFIN
Proposed Sale
52,084$19.34$1.0M—

View →

Jun 16, 2026Jun 18 12:11 AMHarlan S RobinsChief Scientific Officer
Sale
6,160$18.01$110.9K1,405,898(D)

View →

Jun 15, 2026Jun 18 12:11 AMHarlan S RobinsChief Scientific Officer
Sale
100,000$17.37$1.7M1,412,058(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 10, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
15,122$12.14403,539(D)

View →

Mar 9, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14403,939(D)

View →

Mar 6, 2026Mar 11 12:04 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14415,820(D)

View →

Mar 3, 2026Mar 6 1:05 AMMichelle Renee GriffinDirector
Option Exercise
48,044$3.990(D)

View →

Mar 5, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14427,701(D)

View →

Mar 4, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14439,582(D)

View →

Mar 3, 2026Mar 6 12:42 AMJulie RubinsteinPresident and COO
Option Exercise
26,603$12.14451,463(D)

View →

Feb 4, 2026Feb 7 12:30 AMKyle PiskelChief Financial Officer
Option Exercise
2,145$12.142,146(D)

View →

← Previous

Page 4 of 4